TrialClinical and translational science2026

Population Pharmacokinetics and Exposure-Response Analyses of Savolitinib Alone or in Combination With Osimertinib in Patients With Locally Advanced or Metastatic Solid Tumors.

Azar Shahraz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.